We serve Chemical Name:4-(Methylsulfanyl)-2-nitroaniline CAS:23153-09-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(Methylsulfanyl)-2-nitroaniline
CAS.NO:23153-09-5
Synonyms:AC-2770;1-amino-4-methylthio-2-nitrobenzene;4-methylthio-2-nitroaniline;4-(Methylsulfanyl)-2-nitroaniline;2-nitro-4-methylthioaniline;4-methylmercapto-2-nitroaniline;Benzenamine, 4-(methylthio)-2-nitro-
Molecular Formula:C7H8N2O2S
Molecular Weight:184.216
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:343.4±27.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.642
PSA:97.14000
Exact Mass:184.030655
LogP:2.42
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like AC-2770 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenamine, 4-(methylthio)-2-nitro- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(Methylsulfanyl)-2-nitroaniline Use and application,2-nitro-4-methylthioaniline technical grade,usp/ep/jp grade.
Related News: Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations. 4-(Methylsulfanyl)-2-nitroaniline manufacturer Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules. 4-(Methylsulfanyl)-2-nitroaniline supplier The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. 4-(Methylsulfanyl)-2-nitroaniline vendor Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the global pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules. 4-(Methylsulfanyl)-2-nitroaniline factory A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.
